Glaxo Wellcome: Clinical Trials

121 trials sponsored by Glaxo Wellcome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

113 completed, 5 unknown, 2 withdrawn, 1 terminated. 39 Not applicable, 32 Phase 2, 25 Phase 3, 19 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable39Completed 39
Phase 232Completed 30, Terminated 1, Withdrawn 1
Phase 325Completed 21, Unknown 4
Phase 119Completed 18, Withdrawn 1
Phase 46Completed 5, Unknown 1

Follow Glaxo Wellcome: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
Lamivudine/Zidovudine, Nelfinavir mesylate, Aldesleukin - HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)3982003-02-012015-03-09
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
Ritonavir, Abacavir sulfate, Nelfinavir mesylate - HIV Infections
Phase 3UnknownGlaxo Wellcome6242000-11-012005-06-24
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
Abacavir sulfate, Nelfinavir mesylate, Lamivudine - HIV Infections
Phase 3UnknownGlaxo Wellcome2102000-11-012005-06-24
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
Lamivudine/Zidovudine, Abacavir sulfate, Lamivudine - HIV Infections, Lipodystrophy
Phase 4CompletedGlaxo Wellcome1002000-05-012005-06-24
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
Abacavir sulfate, Lamivudine and Zidovudine, Lamivudine/Zidovudine, Abacavir sulfate - HIV Infections
Phase 4CompletedGlaxo Wellcome401999-10-012005-06-24
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
Efavirenz, Lamivudine, Zidovudine - HIV Infections
Phase 2CompletedGlaxo Wellcome1999-09-012005-06-24
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
Lamivudine/Zidovudine, Abacavir sulfate, Nelfinavir mesylate - HIV Infections
Phase 4CompletedGlaxo Wellcome2301999-09-012005-06-24
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment
Hydroxyurea, Abacavir sulfate, Efavirenz - HIV Infections
Phase 4CompletedGlaxo Wellcome1501999-07-012005-06-24
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
Indinavir sulfate, Nelfinavir mesylate, Lamivudine - HIV Infections
Phase 2CompletedGlaxo Wellcome1999-06-012005-06-24
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
Valacyclovir hydrochloride - Herpes Simplex, HIV Infections
Phase 3UnknownGlaxo Wellcome1999-06-012005-06-24
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
Abacavir sulfate, Amprenavir, Lamivudine - HIV Infections
Phase 3CompletedGlaxo Wellcome1999-04-012005-06-24
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
Indinavir sulfate, Abacavir sulfate, Amprenavir - HIV Infections
Phase 2CompletedGlaxo Wellcome1001999-03-012005-06-24
Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
eniluracil, conventional colon surgery - Colorectal Cancer
Phase 2CompletedUniversity of Alabama at Birmingham281998-09-012015-06-15
Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.
Carbamazepine, Gabapentin, Lamotrigine - Seizures
Phase 3CompletedUS Department of Veterans Affairs7201998-01-012023-10-30
A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
Atevirdine mesylate, Zidovudine, Zalcitabine - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302021-11-04
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
Abacavir sulfate, Lamivudine and Zidovudine, Lamivudine/Zidovudine, Abacavir sulfate - HIV Infections
Phase 3UnknownGlaxo Wellcome2302005-06-24
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
Indinavir sulfate, Lamivudine/Zidovudine, Abacavir sulfate - HIV Infections
Phase 3CompletedGlaxo Wellcome5502005-06-24
Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
Sulfamethoxazole-Trimethoprim - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3702021-11-04
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
Azithromycin, Atovaquone, Sulfamethoxazole-Trimethoprim - Bacterial Infections, Pneumonia, Pneumocystis Carinii
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)6902021-11-04
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
Atovaquone - Pneumonia, Pneumocystis Carinii, HIV Infections
Not applicableCompletedGlaxo Wellcome2005-06-24

Showing 20 of 121. Sign in to see all of them.

Conditions studied

HIV Infections (119)  ·  Acquired Immunodeficiency Syndrome (57)  ·  AIDS-Related Complex (47)  ·  Pneumonia, Pneumocystis (9)  ·  AIDS-Related Opportunistic Infections (7)  ·  Herpes Simplex (6)  ·  AIDS Dementia Complex (4)  ·  Herpes Genitalis (4)  ·  Anus Diseases (3)  ·  Chickenpox (3)  ·  Encephalitis (3)  ·  Herpes Zoster (3)  ·  Lipodystrophy (3)  ·  Patient Compliance (3)  ·  Toxoplasmosis (3)

Interventions

Zidovudine (61)  ·  abacavir (30)  ·  Lamivudine (23)  ·  Didanosine (18)  ·  amprenavir (18)  ·  lamivudine, zidovudine drug combination (10)  ·  Nelfinavir (9)  ·  Zalcitabine (9)  ·  Acyclovir (7)  ·  Atovaquone (7)  ·  Indinavir (7)  ·  efavirenz (7)  ·  Valacyclovir (6)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (5)  ·  Stavudine (4)

Countries

United States (116)  ·  Puerto Rico (21)  ·  Canada (9)  ·  France (3)  ·  Germany (3)  ·  Tanzania (3)  ·  Australia (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Sweden (1)

Top investigators

E Connor (2)  ·  Fischl MA (2)  ·  M Niu (2)  ·  Merigan TC (2)  ·  Reichman R (2)  ·  A Collier (1)  ·  A Pesce (1)  ·  B Luft (1)  ·  B Stretcher (1)  ·  Baker C (1)  ·  Balfour HH (1)  ·  Black JR (1)  ·  Bryson Y (1)  ·  C Hall (1)  ·  Cavert W (1)

Results publications

PMID 20103953, PMID 36099671